N0733: Phase II trial of capecitabine and lapatinib +/- cixutumumab in HER2 positive breast cancer
- Citation:
- J Clin Oncol vol 28 (15s) abstr TPS129
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- P. Haluska M. M. Reinholz A. C. Dueck H. M. Linden W. L. Lingle A. M. Bernath Jr M. C. Arbushites H. Youssoufian H. X. Chen E. A. Perez
- Networks:
- Study
- NCCTG-N0733
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: